MX5449E - Procedimiento para preparar acidos hidroxidifosfonicos - Google Patents

Procedimiento para preparar acidos hidroxidifosfonicos

Info

Publication number
MX5449E
MX5449E MX787445U MX744578U MX5449E MX 5449 E MX5449 E MX 5449E MX 787445 U MX787445 U MX 787445U MX 744578 U MX744578 U MX 744578U MX 5449 E MX5449 E MX 5449E
Authority
MX
Mexico
Prior art keywords
hydroxidiphosphonic
acids
preparing
procedure
preparing hydroxidiphosphonic
Prior art date
Application number
MX787445U
Other languages
English (en)
Inventor
Helmut Blum
Hans-Ulrich Hempel
Karl-Heinz Worms
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of MX5449E publication Critical patent/MX5449E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00—Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • C02F5/10—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
    • C02F5/14—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/36—Organic compounds containing phosphorus
    • C11D3/361—Phosphonates, phosphinates or phosphonites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
MX787445U 1977-10-07 1978-10-06 Procedimiento para preparar acidos hidroxidifosfonicos MX5449E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2745083A DE2745083C2 (de) 1977-10-07 1977-10-07 Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
MX5449E true MX5449E (es) 1983-08-09

Family

ID=6020869

Family Applications (1)

Application Number Title Priority Date Filing Date
MX787445U MX5449E (es) 1977-10-07 1978-10-06 Procedimiento para preparar acidos hidroxidifosfonicos

Country Status (6)

Country Link
US (1) US4267108A (es)
EP (1) EP0001584B1 (es)
JP (1) JPS5461125A (es)
DE (1) DE2745083C2 (es)
IT (1) IT1099758B (es)
MX (1) MX5449E (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
DE3142517A1 (de) * 1981-10-27 1983-05-05 Chemische Fabrik Budenheim Rudolf A. Oetker, 6501 Budenheim Verfahren zur herstellung eines phosphonsaeuregemisches
DE19675047I2 (de) * 1982-04-15 2003-06-12 Gentili Ist Spa Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure
DE3334211A1 (de) * 1983-09-22 1985-04-04 Henkel KGaA, 4000 Düsseldorf Dihydroxyalkandiphosphonsaeuren
DE3434667A1 (de) * 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
IT1196315B (it) * 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DE3540150A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3640938A1 (de) * 1986-11-29 1988-06-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel
US4868164A (en) * 1986-12-19 1989-09-19 Norwich Eaton Pharmaceuticals, Inc. Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
DE3700772A1 (de) * 1987-01-13 1988-07-21 Inst Khim Kinetiki I Gorenija Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
DE3811763C2 (de) * 1988-04-08 1993-10-07 Jungbunzlauer Ladenburg Gmbh Wäßrige Dispersion von Gips in Form von Calciumsulfatdihydrat und deren Verwendung als Füllstoff und Streichpigment bei der Papier- und Kartonherstellung
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
DE69023844T2 (de) * 1989-09-06 1996-06-20 Merck & Co Inc Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
AU666741B2 (en) * 1992-05-29 1996-02-22 Procter & Gamble Pharmaceuticals, Inc., The Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
DE69319732T2 (de) * 1992-05-29 1999-02-11 Procter & Gamble Pharma Quaternare stickstoff-enthaltende phosphonat-verbindungen zur behandlung abnormalen calzium und phosphat-metabolismus sowie zahnsteinbildung
CA2136818C (en) * 1992-05-29 2000-01-18 Susan M. Kaas Sulfur-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US5336316A (en) * 1993-05-06 1994-08-09 Bj Services Company Cementing composition and method using phosphonated polymers to improve cement slurry properties
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
US5591730A (en) * 1993-10-12 1997-01-07 The Regents Of The University Of California Inhibition of urinary calculi growth
GB2285053A (en) * 1993-12-23 1995-06-28 Procter & Gamble Rinse aid composition
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
US5840472A (en) 1996-02-07 1998-11-24 Fuji Photo Film Co., Ltd. Developer for silver halide photographic photosensitive material
AR024462A1 (es) 1999-07-01 2002-10-02 Merck & Co Inc Tabletas farmaceuticas
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
US6562974B2 (en) * 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US6409824B1 (en) 2000-04-25 2002-06-25 United States Gypsum Company Gypsum compositions with enhanced resistance to permanent deformation
PL194770B1 (pl) * 2001-03-19 2007-07-31 Adamed Sp Z Oo Sposób wytwarzania kwasu rizedronowego
RU2294203C2 (ru) * 2001-12-21 2007-02-27 Дзе Проктер Энд Гэмбл Компани Способ лечения костных нарушений
ITMI20020908A1 (it) * 2002-04-29 2003-10-29 Chemi Spa Processo di preparazione di sodio alendronato
KR100642961B1 (ko) 2002-05-10 2006-11-10 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
JP4485117B2 (ja) * 2002-06-27 2010-06-16 日東電工株式会社 保護剥離用フィルム
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
PT1790347E (pt) * 2002-12-20 2015-02-05 Hoffmann La Roche Formulação de ibandronato a dose elevada
US20040206932A1 (en) * 2002-12-30 2004-10-21 Abuelyaman Ahmed S. Compositions including polymerizable bisphosphonic acids and methods
EP1653913B1 (en) * 2003-08-12 2012-05-23 3M Innovative Properties Company Self-etching dental compositions and methods
CN101018534B (zh) * 2004-07-08 2012-07-04 3M创新有限公司 牙科的方法，组合物，和包括酸敏感染料的试剂盒
WO2006020760A1 (en) * 2004-08-11 2006-02-23 3M Innovative Properties Company Self-adhesive compositions including a plurality of acidic compounds
WO2008076739A2 (en) * 2006-12-13 2008-06-26 3M Innovative Properties Company Methods of using a dental composition having an acidic component and a photobleachable dye
JP5588597B2 (ja) 2007-03-23 2014-09-10 富士フイルム株式会社 導電性材料の製造方法及び製造装置
US8012909B2 (en) 2007-03-27 2011-09-06 Fujifilm Corporation Heat-sensitive transfer image-forming method
JP2008238737A (ja) 2007-03-28 2008-10-09 Fujifilm Corp 感熱転写受像シート及びその製造方法
JP2008238736A (ja) 2007-03-28 2008-10-09 Fujifilm Corp 感熱転写受像シート
JP4878327B2 (ja) 2007-03-30 2012-02-15 富士フイルム株式会社 感熱転写受像シートおよびその製造方法
EP2009977A3 (en) 2007-05-09 2011-04-27 FUJIFILM Corporation Electromagnetic shielding film and optical filter
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
PL407922A1 (pl) 2014-04-16 2015-10-26 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Nowe bisfosfoniany i ich zastosowanie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE579012A (es) * 1958-09-06 1900-01-01
NL280425A (es) 1961-07-03
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
DE2343196C3 (de) * 1973-08-27 1980-01-10 Henkel Kgaa, 4000 Duesseldorf Aiacycloalkan-2^-diphosphonsäuren oder deren wasserlösliche Salze
US3925453A (en) * 1974-01-25 1975-12-09 Monsanto Co Quaternary aminoalkylene phosphonic acids and method of preparation
DE2405254C2 (de) 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
ES456541A1 (es) * 1976-06-09 1978-02-16 Benckiser Knapsack Gmbh Procedimiento para la preparacion de acidos n-fosfonometilen-monoaminoalcanmonofosfonicos y -polifosfonicos yno acidos n-fosfonometilen-diaminoalcanpolifosfonicos.

Also Published As

Publication number Publication date
JPS6121479B2 (es) 1986-05-27
EP0001584A1 (de) 1979-05-02
US4267108A (en) 1981-05-12
EP0001584B1 (de) 1982-06-30
JPS5461125A (en) 1979-05-17
IT7828405A0 (it) 1978-10-04
IT1099758B (it) 1985-09-28
DE2745083C2 (de) 1985-05-02
DE2745083A1 (de) 1979-04-12

Similar Documents

Publication Publication Date Title
MX5449E (es) Procedimiento para preparar acidos hidroxidifosfonicos
AR230452A1 (es) Procedimiento para preparar compuestos de acidos 7-sustituido-3-cefem-4-carboxilicos
ES490764A0 (es) Procedimiento para preparar esteres de acil-carnitinas
AR219150A1 (es) Procedimiento para preparar nuevos derivados de aminoazucares
MX5604E (es) Procedimiento para preparar aril-hidantoina
AR231635A1 (es) Procedimiento para preparar acidos azabiciclicos
MX147968A (es) Procedimiento para preparar acidos de polieteramida
MX5535E (es) Procedimiento para preparar 2-alfa-ciano-3-oxo-esteroides
MX143361A (es) Procedimiento para preparacion de azinas
MX147874A (es) Procedimiento para preparar compuestos 2-fenoxi-5-trifluorometilpiridina
IT8047797A0 (it) Procedimento per preparare d-alfaamminoacidi
MX151851A (es) Procedimiento mejorado para preparar derivados de triacina
ES495404A0 (es) Procedimiento para preparar esteres
AR223463A1 (es) Procedimiento para obtener acidos alpha-fluormetil-alpha-amino-alcanoicos sustituidos
MX149268A (es) Procedimiento para preparar acidos diperoxidicarboxilicos alifaticos
AR219549A1 (es) Procedimiento para preparar rifampicina
AR222815A1 (es) Procedimiento para la preparacion de acidos(alfa-trifluorometil-mercapto-propionil)-pirrolidinil-o tiazolidinil-carboxilicos
MX5434E (es) Procedimiento para preparar cicloprofilcarboxilatos
MX5160E (es) Procedimiento mejorado para preparar derivados de aminoalcoholes
MX5398E (es) Procedimiento para preparar esteres de alfa-ciano-bencilo
MX5208E (es) Procedimiento para preparar diclorovinilciclobutanonas
AR223161A1 (es) Procedimiento para preparar n-etiletilendiamina
MX5705E (es) Procedimiento para preparar esteres de(s) alfa-ciano-3-fenoxibencilo
AR226210A1 (es) Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona
MX4779E (es) Procedimiento para preparar di-n-propila-cetonitrilo